Narrow-Band UVB Therapy

On this page

NB-UVB Basics - The Healing Light

  • A specific type of phototherapy utilizing a narrow range of UVB light.
  • Mechanism: Primarily immunomodulatory; induces apoptosis of pathogenic T-lymphocytes, alters cytokine profiles (e.g., ↓IL-17, ↑IL-10).
  • Advantages: Greater efficacy and lower erythemogenic potential compared to broadband UVB.
  • Preferred for psoriasis, vitiligo, atopic dermatitis. UV light penetration into skin layers

⭐ NB-UVB primarily emits light in the 311-313 nm range, considered the most effective and safest part of the UVB spectrum for treating skin diseases.

NB-UVB Indications - Skin's Best Friend

  • Psoriasis: Chronic plaque, guttate (second-line).
  • Vitiligo: Generalized, especially facial/truncal.
  • Atopic Dermatitis: Moderate to severe, chronic.
  • Mycosis Fungoides: Early-stage (patch/plaque).
  • Polymorphic Light Eruption (PLE): Prophylaxis.
  • Chronic Urticaria: Symptomatic relief.
  • Lichen Planus: Generalized, pruritic.
  • Pruritus: Uremic, cholestatic, HIV-associated.

Patient receiving Narrow-Band UVB Therapy

⭐ For vitiligo, NB-UVB is often considered a first-line treatment, especially for generalized disease.

📌 Mnemonic: "People Value All Medical Professionals Carefully Listening Patiently" (Psoriasis, Vitiligo, Atopic dermatitis, Mycosis fungoides, PLE, Chronic urticaria, Lichen planus, Pruritus).

NB-UVB Cautions - Safety First Rays

  • Absolute Contraindications:
    • Lupus erythematosus
    • Dermatomyositis
    • History of skin cancer (melanoma, squamous cell carcinoma)
    • Genetic photosensitivity disorders (e.g., Xeroderma Pigmentosum)
    • Pemphigus / Pemphigoid (can be exacerbated)
    • Concurrent use of photosensitizing drugs (e.g., psoralens, retinoids, tetracyclines, thiazides) without specific protocols.
  • Relative Contraindications/Cautions:
    • History of multiple non-melanoma skin cancers
    • Severe photodamage
    • Cataracts or aphakia (unless eyes are protected)
    • Immunosuppression (e.g., post-transplant)
    • Children < 10 years (use with caution)
    • Pregnancy (generally considered safe, but discuss risks)

⭐ Patients with a history of melanoma or conditions like Xeroderma Pigmentosum are absolute contraindications for NB-UVB therapy.

⚠️ Always shield eyes, genitalia, and unaffected skin. Monitor for erythema, blistering, and long-term carcinogenesis risk. 📌 Skin Cancer Always Makes Phototherapy Scary (SCAMPS - Skin Cancer, Autoimmune, Medications, Photosensitivity, Severe damage).

NB-UVB Protocol - Dose & Delivery

  • Initial Dose:
    • Determined by Minimal Erythema Dose (MED) test (50-70% of MED).
    • Or, by skin phototype (e.g., Fitzpatrick I-II: ~0.2 J/cm²; III-IV: ~0.3 J/cm²).
  • Dose Escalation:
    • Gradual increase, typically 10-20% per treatment, if no adverse erythema.
    • Adjust based on skin reaction: maintain, decrease, or skip if significant redness.
  • Maximum Dose & Duration:
    • Individualized; aim for therapeutic effect without burns. Monitor cumulative exposure.

⭐ Treatment frequency is typically 2-3 times per week, with non-consecutive days to allow skin recovery.

NB-UVB Reactions - Sunburn's Cousins

  • Acute Reactions (Sunburn-like):
    • Erythema: Most common, dose-dependent. Mild cases resolve in 24 hrs.
    • Pruritus (itching): Common; manage with emollients, antihistamines.
    • Xerosis (dry skin): Frequent; emphasize regular moisturizer use.
    • Blistering: Rare, indicates significant overexposure; adjust dose.
    • Herpes simplex reactivation: Uncommon; consider prophylaxis if history.
  • Chronic Reactions:
    • Photoaging: Premature skin aging (wrinkles, lentigines) with long-term exposure.
    • Photocarcinogenesis: Theoretical NMSC risk. Higher with prior PUVA/immunosuppression. Regular skin surveillance vital.

⭐ The most common acute side effect of NB-UVB is asymptomatic erythema (mild sunburn), which usually resolves within 24 hours.

High‑Yield Points - ⚡ Biggest Takeaways

  • NB-UVB uses a peak wavelength of 311 nm (311-313 nm range).
  • Main action: immunomodulation via T-cell apoptosis and cytokine alteration.
  • Prime indications: psoriasis (widespread), vitiligo, atopic dermatitis, early mycosis fungoides.
  • Superior to BB-UVB: ↑ efficacy for psoriasis, ↓ erythema, ↓ cumulative dose.
  • Treatment protocol: 2-3 sessions/week; initial dose ~70% MED or fixed low dose.
  • Common acute effects: erythema, pruritus; chronic: photoaging, (lower) skin cancer risk.
  • Avoid in xeroderma pigmentosum, SLE, history of melanoma or multiple skin cancers.

Practice Questions: Narrow-Band UVB Therapy

Test your understanding with these related questions

A nurse got accidental prick from the HIV infected needle. Which of the following statements is false regarding the management of this nurse?

1 of 5

Flashcards: Narrow-Band UVB Therapy

1/9

UVB has a _____ skin cancer risk than PUVA

TAP TO REVEAL ANSWER

UVB has a _____ skin cancer risk than PUVA

lesser::Lesser/Greater

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial